At the time of writing, CME Group Inc [CME] stock is trading at $197.08, up 0.81%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CME shares have gain 1.54% over the last week, with a monthly amount drifted -2.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on June 21, 2024, when JP Morgan downgraded its rating to a Underweight and also revised its price target to $187 from $206. Previously, Barclays downgraded its rating to Equal Weight on January 08, 2024, and dropped its price target to $222. On January 03, 2024, downgrade downgraded it’s rating to Sell but maintained its price target of $195 on the stock. BofA Securities upgraded its rating to a Neutral and increased its price target to $204 on September 06, 2023. Barclays initiated its recommendation with a Overweight and recommended $215 as its price target on June 28, 2023. Credit Suisse upgraded its rating to Outperform for this stock on January 05, 2023, but kept the price target unchanged to $191. In a note dated October 12, 2022, Deutsche Bank upgraded an Buy rating on this stock and revised its target price from $212 to $200.
For the past year, the stock price of CME Group Inc fluctuated between $175.71 and $222.63. Currently, Wall Street analysts expect the stock to reach $220.4 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $197.08 at the most recent close of the market. An investor can expect a potential return of 11.83% based on the average CME price forecast.
Analyzing the CME fundamentals
According to CME Group Inc [NASDAQ:CME], the company’s sales were 5.63B for trailing twelve months, which represents an 3.21% jump. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.62%, Pretax Profit Margin comes in at 0.73%, and Net Profit Margin reading is 0.57%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.12 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 195.94 points at the first support level, and at 194.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 198.27, and for the 2nd resistance point, it is at 199.46.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 12.61, the price to book ratio is 2.61 and price to earnings (TTM) ratio is 22.45.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Jun 25 ’24 when 312.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Jun 25 ’24 to buy 14.0 shares. Meanwhile, Director Carey Charles P sold 3000.0 shares on Jun 13 ’24.
